Exhibit 10.7
CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE REGISTRANT HAS DETERMINED THAT IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.
AMENDMENT NO. 6
TO TRANSITION SERVICES AGREEMENT
This Amendment No. 6 (“Amendment No. 6”) to the Agreement (as defined below) is made effective as of August 29, 2025 (the “Effective Date”) by and among BridgeBio Services Inc., a Delaware corporation (“BBIO”) and TheRas, Inc., a Delaware corporation (“BBOT”), BridgeBio Pharma LLC (“BBP LLC”), and BridgeBio Oncology Therapeutics, Inc. (“PubCo”). BBIO, BBOT, BBP LLC and PubCo may be referred to herein by name or individually, as a “Party” and collectively, as the “Parties.” Capitalized terms used and not otherwise defined herein shall have the meanings given such terms in the Agreement (as defined below) to the extent defined therein.
WHEREAS, BBIO and BBOT entered into that certain Transition Services Agreement, dated April 30, 2024, as amended (the “Agreement”);
WHEREAS, the Agreement was subsequently amended to add BBP LLC and PubCo as Parties to the Agreement; and
WHEREAS, the Parties now wish to further amend the Agreement to update the Service Schedule on Exhibit A thereto, retroactive to July 1, 2025.
NOW, THEREFORE, in consideration of the covenants, conditions and undertakings hereinafter set forth, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereby agree as follows:
1. Amendment to Service Schedule. Exhibit A of the Agreement is hereby deleted in its entirety and replaced with the following new Exhibit A attached hereto.
2. Miscellaneous. This Amendment No. 6 together with the Agreement constitute the entire agreement of the Parties with respect to the matters set forth in this Amendment No. 6 and there are no other agreements, commitments or understandings among the Parties with respect to the matters set forth herein. All terms and conditions of the Agreement not expressly amended herein shall remain in full force and effect. The terms and conditions of this Amendment No. 6 shall prevail over any conflicting terms and conditions in the Agreement with regard to the subject matter herein. This Amendment No. 6 shall be construed and enforced in accordance with the laws of California.
[Signature Page Follows]
IN WITNESS WHEREOF, each Party hereto has executed this Amendment No. 6 as of the date first above written.
BRIDGEBIO SERVICES INC.
By: /s/ Neil Kumar
Name: Neil Kuman
Title: President and Chief Executive Officer
BRIDGEBIO PHARMA LLC
By: /s/ Neil Kumar
Name: Neil Kumar
Title: President and Chief Executive Officer
THERAS, INC.
By: /s/ Eli Wallace
Name: Eli Wallace
Title: Chief Executive Officer
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
By: /s/ Eli Wallace
Name: Eli Wallace
Title: Chief Executive Officer
2
EXHIBIT A
FORM OF SERVICE SCHEDULE
Services as of July 1, 2025
[***]
3